JiangSu WuZhong Pharmaceutical Development Co., Ltd. engages in pharmaceutical, medical cosmetology, investment, and other industries in China and internationally. It provides genetic and chemical drugs in the fields of anti-virus, anti-infection, immune regulation, anti-tumor, digestive system, cardiovascular, etc.; and modern traditional Chinese medicine. The company also offers high-end injection filling products for medical cosmetology. In addition, the company provides abidol hydrochloride tablets, pidotimod oral solution, trimetazidine dihydrochloride tablets, methocarbamol injection, prolonium iodide for injection, carbazochrome sodium sulfonate tablets, lansoprazole for injection, omeprazole sodium for injection, and lianqin pearl dropping pills. It offers its products in various forms, such as hard capsules, granules, tablets, oral solutions, dropping pills, emulsions, large-volume injections, and small-volumes injections, powder injections, freeze-dried powder injections and raw materials, and other dosage forms. The company was founded in 1994 and is based in Suzhou, China.
Metrics to compare | 600200 | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship Relationship600200PeersSector | |
|---|---|---|---|---|
P/E Ratio | −3.3x | 12.3x | −0.6x | |
PEG Ratio | 0.05 | 0.01 | 0.00 | |
Price/Book | 0.1x | 1.9x | 2.6x | |
Price / LTM Sales | 0.2x | 3.5x | 3.4x | |
Upside (Analyst Target) | - | 28.3% | 44.4% | |
Fair Value Upside | Unlock | 6.2% | 6.1% | Unlock |